AI Article Synopsis

  • - Chronic inflammation in patients with inflammatory rheumatic diseases (IRD) leads to increased cardiovascular (CV) risks, contributing to higher mortality rates compared to the general population due to premature atherosclerosis.
  • - Effective CV risk assessment and early diagnosis of silent cardiovascular disease (CVD) are critical for improving long-term outcomes, yet standard care often falls short in these areas.
  • - Arterial stiffness, measured through methods like pulse wave velocity (PWV), serves as a valuable biomarker for predicting cardiovascular events and stratifying risk in patients with vasculitis, highlighting the need for better monitoring and management strategies.

Article Abstract

Chronic inflammation represents the cornerstone of the raised cardiovascular (CV) risk in patients with inflammatory rheumatic diseases (IRD), including vasculitis. Standardized mortality ratios in these patients are higher as compared to the general population, and the excess of premature mortality is due to early atherosclerotic events. Thus, IRD patients need appropriate CV risk assessment and management according to this CV disease (CVD) burden. Adequate control of CV risk is still lacking in usual care, but early diagnosis of silent and subclinical CVD is crucial to improve the long-term prognosis of these patients. Increased arterial stiffness may provide a pathophysiological link between inflammation and increased cardiovascular risk. Several noninvasive methods are now available to estimate artery stiffness in the clinical setting, including pulse wave velocity assessment. The independent predictive value of arterial stiffness for cardiovascular events has been demonstrated in general as well as in selected populations, and reference values adjusted for age and blood pressure have been suggested. Thus, arterial stiffness is an interesting biomarker for cardiovascular risk stratification. This systematic review summarizes the additional value that PWV measurement can provide in the setting of vasculitis, with a focus in the different clinical stages and CV risk prevention. This systematic review is registered with registration number: Prospero CRD42021259603.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133451PMC
http://dx.doi.org/10.3389/fmed.2022.824630DOI Listing

Publication Analysis

Top Keywords

arterial stiffness
16
systematic review
12
cardiovascular risk
12
risk
6
arterial
4
stiffness adult
4
adult onset
4
onset vasculitis
4
vasculitis systematic
4
review chronic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!